BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease today announced that John F. Thero, Amarin's President, is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012, at 11:30 a.m. ET. This conference will be held at the Waldorf Astoria Hotel in New York City. A live audio webcast of the presentation will be available at:
